tiprankstipranks
Advertisement
Advertisement

IDYA Stock Latest News

IDEAYA Biosciences: Buy Rating Reiterated as Precision Oncology Pipeline Advances and $62 Price Target Maintained
RatingsIDEAYA Biosciences: Buy Rating Reiterated as Precision Oncology Pipeline Advances and $62 Price Target Maintained
4d ago
IDYA
Ideaya Biosciences initiates monotherapy expansion in IDE892 trial
PremiumThe Fly
Ideaya Biosciences initiates monotherapy expansion in IDE892 trial
4d ago
IDYA
Ideaya Biosciences price target lowered to $63 from $65 at Truist
PremiumThe Fly
Ideaya Biosciences price target lowered to $63 from $65 at Truist
24d ago
IDYA
Ideaya Biosciences price target lowered to $48 from $53 at RBC Capital
PremiumThe Fly
Ideaya Biosciences price target lowered to $48 from $53 at RBC Capital
24d ago
IDYA
IDEAYA Biosciences Shareholders Back Leadership, Governance Changes
PremiumCompany Announcements
IDEAYA Biosciences Shareholders Back Leadership, Governance Changes
1M ago
8K
IDYA
Ideaya Advances IDE034 Into First-in-Human Trial for Advanced Solid Tumors
PremiumCompany AnnouncementsIdeaya Advances IDE034 Into First-in-Human Trial for Advanced Solid Tumors
1M ago
IDYA
Ideaya Biosciences elects CEO Yujiro Hata as chairman
Premium
The Fly
Ideaya Biosciences elects CEO Yujiro Hata as chairman
1M ago
IDYA
Ideaya Biosciences enrolls first patient in IDE892 trial
Premium
The Fly
Ideaya Biosciences enrolls first patient in IDE892 trial
2M ago
IDYA
IDEAYA Biosciences Raises $324 Million in Equity Offering
PremiumCompany Announcements
IDEAYA Biosciences Raises $324 Million in Equity Offering
2M ago
8K
IDYA
Ideaya Biosciences 5.56M share Spot Secondary priced at $27.00
PremiumThe Fly
Ideaya Biosciences 5.56M share Spot Secondary priced at $27.00
2M ago
IDYA
Closing Bell Movers: Vail Resorts down 4% as earnings miss estimates
PremiumThe Fly
Closing Bell Movers: Vail Resorts down 4% as earnings miss estimates
2M ago
AVO
MTN
Ideaya Biosciences $300M Spot Secondary re-offered at $27.00
PremiumThe Fly
Ideaya Biosciences $300M Spot Secondary re-offered at $27.00
2M ago
IDYA
Ideaya Biosciences announces $300M common stock offering
PremiumThe FlyIdeaya Biosciences announces $300M common stock offering
2M ago
IDYA
Analyst Reiterates Buy on IDEAYA, Citing Strong Oncology Pipeline and Partnerships with Unchanged $62 Price Target
Premium
Ratings
Analyst Reiterates Buy on IDEAYA, Citing Strong Oncology Pipeline and Partnerships with Unchanged $62 Price Target
2M ago
IDYA
IDEAYA, Roche launch PRMT5 and pan-RAS collaboration
Premium
Company Announcements
IDEAYA, Roche launch PRMT5 and pan-RAS collaboration
2M ago
8K
IDYA
Ideaya Biosciences announces IDE892 collaboration with Roche
PremiumThe Fly
Ideaya Biosciences announces IDE892 collaboration with Roche
2M ago
CHRO
IDYA
IDEAYA Highlights Positive Phase 2/3 Darovasertib Trial Results
PremiumCompany Announcements
IDEAYA Highlights Positive Phase 2/3 Darovasertib Trial Results
2M ago
8K
IDYA
Ideaya Biosciences, Servier present data from Phase 2/3 OptimUM-02 trial
PremiumThe Fly
Ideaya Biosciences, Servier present data from Phase 2/3 OptimUM-02 trial
2M ago
IDYA
Ideaya Biosciences management to meet with Cantor
PremiumThe Fly
Ideaya Biosciences management to meet with Cantor
2M ago
IDYA
Ideaya’s IDE574 Trial Signals New Optionality in Advanced Solid Tumors and Breast Cancer
PremiumCompany AnnouncementsIdeaya’s IDE574 Trial Signals New Optionality in Advanced Solid Tumors and Breast Cancer
2M ago
IDYA
Ideaya Biosciences price target lowered to $50 from $52 at Mizuho
Premium
The Fly
Ideaya Biosciences price target lowered to $50 from $52 at Mizuho
3M ago
IDYA
IDEAYA Biosciences Files New Shelf Registration Statement
Premium
Company Announcements
IDEAYA Biosciences Files New Shelf Registration Statement
3M ago
8K
IDYA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >